Meta-Analysis
Copyright ©The Author(s) 2022.
World J Clin Cases. Apr 16, 2022; 10(11): 3436-3448
Published online Apr 16, 2022. doi: 10.12998/wjcc.v10.i11.3436
Table 1 Characteristics of the included studies (n = 14)
No
Ref.
Country
Study design
Sample size
Study participants
Type of ultrasound elastography
Cut-off
Reference standard
Mean age (in years)
1Evans et al[7], 2018United KingdomProspective64Patients with breast cancer receiving NACTShear wave elastographyMean stiffness = 50 kPAAssessment of any invasive cancer cells in the tumour bed at surgical resection after 6 cycles of NACT and an assessment of nodal metastases at axillary surgery52
2Evans et al[8], 2018United KingdomProspective80Patients with breast cancer receiving NACTShear wave elastographyMean stiffness = 83 kPAAssessment of any invasive cancer cells in the tumour bed at surgical resection after 6 cycles of NACT and an assessment of nodal metastases at axillary surgery53
3Falou et al[9], 2013CanadaProspective15Locally advanced breast cancer patients receiving NACTStrain wave elastographyMean strain ratio = 81Histopathological examination following mastectomy45
4Fang et al[10], 2019ChinaProspective60Breast cancer patients with stage IIa-IIIc (T1-T4; N0-N3; M0) and underwent surgery after receiving NACTStrain wave elastographyMean strain ratio = 5.4Pathological examination after surgical resection39
5Fernandes et al[11], 2019CanadaProspective92Patients with biopsy confirmed locally advanced breast cancer receiving NACTStrain wave elastographyElastography score = 4Histopathological examination55
6Hayashi et al[12], 2012JapanRetrospective55Histologically confirmed invasive breast cancer before NACT, and they underwent surgery after completion of NACTStrain wave elastographyElastography score = 4Pathologic response was assessed in surgical specimens of the breast with reference to the standards of the Japanese Breast Cancer Society52
7Jing et al[13], 2016ChinaProspective62Patients with diagnosis of breast carcinoma by ultrasound-guided core needle biopsy who received neoadjuvant chemotherapy followed by surgical excisionShear wave elastographyStiffness threshold-36.1%Pathologic assessments involved a 2-step process. First, samples from core needle biopsies were examined to record the histologic and biologic characteristics of the tumours. These findings were usually combined with the clinical features of the patients to predict the response to neoadjuvant chemotherapy. Second, pathologic responses to neoadjuvant chemotherapy were evaluated according to the Miller-Payne grading criteria49
8Katyan et al[14], 2019IndiaProspective86TNM stage III and T3N0 subset of stage IIb breast cancer patients receiving NACTStrain wave elastographyStrain ratio = 0.1Histopathological examinationNA
9Lee et al[15], 2015KoreaRetrospective71Women with stage II-III invasive breast cancers who received NACTShear wave elastographyMean stiffness = 98.1 kPAHistopathological examinationNA
10Ma et al[16], 2017ChinaProspective71Women confirmed with invasive breast cancer by ultrasound guided core needle biopsy and underwent NACT and subsequent surgical excisionShear and strain wave eastographyStiffness threshold-30.4%; Strain ratio = 6.7Histopathological examination47.3
11Ma et al[17], 2020ChinaProspective43Breast cancer patients who were confirmed to be HER-2 positive by biopsy and puncture and underwent NACTShear wave elastographyMean stiffness = 30 kPAHistopathological examination after surgical resectionNA
12Maier et al[18], 2020GermanyProspective134Histologically confirmed unilateral or bilateral breast cancer and indication for NACTShear wave elastographyShear wave velocity = 3.35Pathological examinations and immunohistochemistry from the core-cut biopsy before and from the surgical specimen after NACT52.1
13Wang et al[19], 2019ChinaProspective65Patients confirmed via biopsy to have breast cancer prior to receiving NACT treatment and they received no other treatmentStrain wave elastographyStrain ratio = 8Histopathology results of the lesion samples isolated in the surgery were compared with those of the biopsy specimens obtained prior to treatment to determine the response to NACT48.3
14Zhang et al[20], 2020ChinaProspective91Patients diagnosed with invasive breast cancer by ultrasound-guided core needle biopsy and received NACT and subsequent surgical interventionShear wave elastographyStiffness threshold–41.4%Histopathological examination46.9